Tumor immune surveillance studies have revealed an association between IL-10 and the development of human cancers such as large B-cell lymphoma, T-cell non-Hodgkin lymphoma, and colon, prostate, breast, gastric, myeloma, and lung cancers [4], [6]–[9], [12]–[22]. Here, IL10 is linked to neoplasm.